Genomics Market Expands with Rising Genomic Research Investments

The global genomics market was valued at USD 46.65 billion in 2025 and is projected to grow from USD 52.46 billion in 2026 to USD 134.22 billion by 2034, registering a CAGR of 12.46% during the forecast period (2026–2034).

The market is witnessing significant growth due to the increasing adoption of precision medicine, rapid advancements in next-generation sequencing (NGS), growing investments in genomics research, and expanding applications across healthcare, agriculture, drug discovery, and diagnostics. Continuous innovations in genomic technologies are enabling researchers and healthcare providers to better understand genetic disorders, develop targeted therapies, and improve disease prevention and personalized treatment strategies.

Key Highlights

• Market Size (2025): USD 46.65 Billion

• Forecast Market Size (2034): USD 134.22 Billion

• Forecast Period: 2026–2034

• CAGR: 12.46%

• Largest Region: North America

• Fastest Growing Region: Asia-Pacific (CAGR: 13.21%)

• Largest Segment: Consumables

• Fastest Growing Segment: Bioinformatics (CAGR: 13.54%)

Market Dynamics

Driver

The growing demand for precision medicine and personalized healthcare is one of the primary drivers of the genomics market. Healthcare providers are increasingly utilizing genomic information to identify disease risks, optimize treatment strategies, and improve patient outcomes. The declining cost of DNA sequencing, combined with advances in next-generation sequencing technologies, has made genomic analysis more accessible for clinical diagnostics, research institutions, and pharmaceutical companies.

In addition, increasing government funding for genomics research, rising investments from biotechnology companies, and expanding collaborations between research organizations and healthcare providers are accelerating innovation across the industry. The integration of artificial intelligence, cloud computing, and big data analytics into genomic research is further enhancing the speed and accuracy of genomic data interpretation.

Restraint

Despite robust market growth, the high cost of advanced genomic technologies and complex data analysis continues to present challenges for widespread adoption. Many healthcare institutions, particularly in developing regions, face budget constraints that limit access to sophisticated sequencing platforms and bioinformatics infrastructure.

Furthermore, concerns related to genomic data privacy, ethical considerations, and regulatory compliance remain significant barriers. The secure storage, management, and sharing of sensitive genetic information require robust cybersecurity measures and standardized regulatory frameworks, which can increase implementation complexity and operational costs.

Opportunity

The expanding application of genomics in oncology, rare disease diagnosis, reproductive health, and infectious disease surveillance presents substantial growth opportunities for the market. Advances in gene editing technologies, including CRISPR-based research, are opening new possibilities for targeted therapies and next-generation drug development.

Moreover, increasing investments in population genomics, companion diagnostics, pharmacogenomics, and agricultural biotechnology are expected to drive long-term market expansion. Emerging economies are also strengthening genomics research infrastructure, creating new opportunities for technology providers, sequencing companies, and healthcare organizations worldwide.

Top Market Players

• Illumina Inc.

• Thermo Fisher Scientific Inc.

• F. Hoffmann-La Roche Ltd.

• Agilent Technologies Inc.

• QIAGEN N.V.

• Danaher Corporation

• Pacific Biosciences of California, Inc.

• Oxford Nanopore Technologies plc

• BGI Genomics Co., Ltd.

• Eurofins Scientific SE

• PerkinElmer Inc.

• Bio-Rad Laboratories, Inc.

• 10x Genomics, Inc.

• Revvity, Inc.

• Merck KGaA

Market Segmentation

By Product & Service

• Instruments

• Consumables

• Services

By Technology

• Sequencing

• PCR

• Microarray

• Nucleic Acid Extraction and Purification

• Others

By Application

• Diagnostics

• Drug Discovery and Development

• Precision Medicine

• Agriculture and Animal Research

• Others

By End User

• Pharmaceutical and Biotechnology Companies

• Hospitals and Clinics

• Academic and Research Institutes

• Diagnostic Laboratories

• Others

By Region

North America

• United States

• Canada

• Mexico

Europe

• Germany

• United Kingdom

• France

• Italy

• Spain

• Rest of Europe

Asia-Pacific

• China

• Japan

• India

• South Korea

• Australia

• Rest of Asia-Pacific

Latin America

• Brazil

• Argentina

• Rest of Latin America

Middle East & Africa

• GCC

• South Africa

• Rest of Middle East & Africa

Unlock Full Report Insights and Strategic Analysis: https://straitsresearch.com/report/genomics-market

Gain access to comprehensive market intelligence, competitive benchmarking, company profiles, technology trends, regional analysis, investment opportunities, innovation strategies, and detailed forecasts designed to support strategic decision-making in the rapidly evolving global genomics market.

About Us

Straits Research is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports.

Contact Us

Email: [email protected]

Tel: +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.)